Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: A case report

doi:10.3748/wjg.14.5474

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2698)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

290

HTML

2234

Figures (1-3)

174

Sum=2698

Sep 21, 2008 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Sep 21, 2008; 14(35): 5474-5477
Published online Sep 21, 2008. doi: 10.3748/wjg.14.5474

Full Size Figure Download Figure

Figure 3 Clinical course of the disease. SNMC: Stronger neo-minophagen C, PGE1: Prostaglandin, mPSL: Methylprednisolone, PSL: Prednisolone, IFN-β: Interferon β.

Citation: Takahashi A, Kanno Y, Takahashi Y, Sakamoto N, Monoe K, Saito H, Abe K, Yokokawa J, Irisawa A, Ohira H. Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: A case report. World J Gastroenterol 2008; 14(35): 5474-5477
URL: https://www.wjgnet.com/1007-9327/full/v14/i35/5474.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5474